Form 4/A for OSCR Oscar Health, Inc.
Accepted 2023-08-15 00:00:00 ET · period of report 2023-06-01 · accession 0001562180-23-006350 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AT | 2023-08-15 | 2023-06-02 | OSCR | Quane Alessandrea C. | EVP, Chief Insurance Off | S - Sale | $7.15 | -16.3K | 213.4K | -7% | -$116.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-02 | S | D | 16,324 | $7.15 | 213,398 | D | — | — | (F1) The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. (F2) On June 5, 2023, the Reporting Person filed a Form 4 that inadvertently reported an incorrect price in Column 4, which was mischaracterized as a weighted average price. The price for this transaction is corrected in Column 4 of this amendment. |